Can Fite Biopharma Ltd ADR (CANF) — Financial Flexibility Index
Can Fite Biopharma Ltd ADR (CANF) has a Financial Flexibility Index of -0.67x as of June 2025. Free cash flow of $-2.38 Million (operating CF $-2.38 Million minus capex $500.00) represents -1% of total liabilities ($3.54 Million). Also explore Can Fite Biopharma Ltd ADR net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Can Fite Biopharma Ltd ADR Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Can Fite Biopharma Ltd ADR across 15 annual periods. Check CANF capital-intensive asset ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Can Fite Biopharma Ltd ADR (2011–2025)
Year-by-year free cash flow to debt coverage for Can Fite Biopharma Ltd ADR. For the full company profile including market capitalisation, see Can Fite Biopharma Ltd ADR (CANF) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.30x | $-9.02 Million | $-9.02 Million | $3.92 Million | ▼ -11.0% |
| 2024 | -2.07x | $-7.63 Million | $-7.64 Million | $3.68 Million | ▲ +8.0% |
| 2023 | -2.25x | $-8.44 Million | $-8.44 Million | $3.75 Million | ▼ -0.4% |
| 2022 | -2.24x | $-10.79 Million | $-10.80 Million | $4.81 Million | ▼ -33.7% |
| 2021 | -1.68x | $-9.85 Million | $-9.86 Million | $5.87 Million | ▲ +51.9% |
| 2020 | -3.49x | $-12.04 Million | $-12.06 Million | $3.45 Million | ▼ -84.7% |
| 2019 | -1.89x | $-10.83 Million | $-10.83 Million | $5.73 Million | ▼ -126.3% |
| 2018 | -0.83x | $-4.12 Million | $-4.16 Million | $4.94 Million | ▲ +58.1% |
| 2017 | -1.99x | $-9.52 Million | $-9.52 Million | $4.78 Million | ▼ -40.5% |
| 2016 | -1.42x | $-8.92 Million | $-8.93 Million | $6.29 Million | ▼ -120.1% |
| 2015 | -0.64x | $-4.61 Million | $-4.65 Million | $7.16 Million | ▲ +70.7% |
| 2014 | -2.20x | $-7.32 Million | $-7.33 Million | $3.33 Million | ▲ +44.5% |
| 2013 | -3.96x | $-8.62 Million | $-8.63 Million | $2.18 Million | ▼ -113.6% |
| 2012 | -1.85x | $-4.34 Million | $-4.35 Million | $2.34 Million | ▲ +45.4% |
| 2011 | -3.40x | $-5.47 Million | $-5.50 Million | $1.61 Million | — |